fluoxetine and imatinib mesylate

fluoxetine has been researched along with imatinib mesylate in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Archer, SL; Michelakis, ED	1
Abid, S; Adnot, S; Amsellem, V; Dubois-Randé, JL; Houssaini, A; Marcos, E; Mouraret, N; Rideau, D; Saker, M; Tissot, CM; Wan, F	1

Reviews

1 review(s) available for fluoxetine and imatinib mesylate

Article	Year
An evidence-based approach to the management of pulmonary arterial hypertension. Current opinion in cardiology, 2006, Volume: 21, Issue:4 Topics: Antihypertensive Agents; Benzamides; Bosentan; Calcium Channel Blockers; Comorbidity; Dichloroacetic Acid; Drug Therapy, Combination; Epoprostenol; Evidence-Based Medicine; Fluoxetine; Humans; Hypertension, Pulmonary; Iloprost; Imatinib Mesylate; Isoxazoles; Phosphodiesterase Inhibitors; Piperazines; Prostaglandins, Synthetic; Pulmonary Artery; Purines; Pyrimidines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Simvastatin; Sulfonamides; Sulfones; Thiophenes; Vasodilator Agents	2006

Article

Year

An evidence-based approach to the management of pulmonary arterial hypertension.

Current opinion in cardiology, 2006, Volume: 21, Issue:4

Topics: Antihypertensive Agents; Benzamides; Bosentan; Calcium Channel Blockers; Comorbidity; Dichloroacetic Acid; Drug Therapy, Combination; Epoprostenol; Evidence-Based Medicine; Fluoxetine; Humans; Hypertension, Pulmonary; Iloprost; Imatinib Mesylate; Isoxazoles; Phosphodiesterase Inhibitors; Piperazines; Prostaglandins, Synthetic; Pulmonary Artery; Purines; Pyrimidines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Simvastatin; Sulfonamides; Sulfones; Thiophenes; Vasodilator Agents

2006

Other Studies

2 other study(ies) available for fluoxetine and imatinib mesylate

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension. American journal of respiratory cell and molecular biology, 2013, Volume: 48, Issue:5 Topics: Animals; Apoptosis; Benzamides; Cell Proliferation; Cells, Cultured; Fluoxetine; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hypertension, Pulmonary; Imatinib Mesylate; Male; Monocrotaline; Myocytes, Smooth Muscle; Phosphorylation; Piperazines; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Pulmonary Artery; Pyrimidines; Rats; Rats, Wistar; Ribosomal Protein S6 Kinases; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases	2013

Article

Year

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.

Chemical research in toxicology, 2010, Volume: 23, Issue:1

Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010

Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension.

American journal of respiratory cell and molecular biology, 2013, Volume: 48, Issue:5

Topics: Animals; Apoptosis; Benzamides; Cell Proliferation; Cells, Cultured; Fluoxetine; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hypertension, Pulmonary; Imatinib Mesylate; Male; Monocrotaline; Myocytes, Smooth Muscle; Phosphorylation; Piperazines; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Pulmonary Artery; Pyrimidines; Rats; Rats, Wistar; Ribosomal Protein S6 Kinases; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases

2013